Feasibility of Using a Structured Daily Diary

Not Applicable

Completed

• Conditions: HIV Infection
• Interventions: Behavioral: Structured daily diary

• Registration Number: NCT01953653
• Lead Sponsor: University of North Carolina, Chapel Hill

Brief Summary

This protocol explores the feasibility and acceptability of using two daily diary methods to analyze state-dependent variables and psychosocial health outcomes in Human Immunodeficiency Virus (HIV)-positive young men who have sex with men (YMSM). The study will explore the potential of diaries for use in feedback-based interventions.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2013-01-19
• Study Start: 2013-02
• Study First Submitted QC: 2013-09-26
• Study First Posted: 2013-10-01
• Primary Completion: 2014-02
• Study Completion: 2014-02
• Status Verified: 2016-03
• Last Update Submitted: 2017-02-27
• Last Update Posted: 2017-02-28

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Male
• Target Recruitment: 67

Inclusion Criteria

• Receives services at one of the selected Adolescent Medicine Trial Unit (AMTU) sites;

• HIV-1 infection as documented in the participant's medical record by at least one of the following criteria:

  • Reactive HIV screening test result with an antibody-based, Food and Drug Administration (FDA)-licensed assay followed by a positive supplemental assay (e.g., HIV-1 Western Blot, HIV-1 indirect immunofluorescence);
  • Positive HIV-1 deoxyribonucleic acid (DNA) polymerase chain reaction (PCR) assay;
  • Plasma HIV-1 quantitative ribonucleic acid (RNA) assay >1,000 copies/mL; or
  • Positive plasma HIV-1 RNA qualitative assay

• Between the ages of 16-24 years, inclusive, at the time of screening;

• Born biologically male and self-identifies as male at the time of screening;

• HIV-infected through sexual behavior;

• At least one self-reported sexual encounter with another man involving oral or anal sex in the past 12 months prior to screening;

• At least one self-reported episode of unprotected vaginal or anal intercourse within the past 90 days prior to screening and/or substance use, defined as at least one occasion in which four or more alcoholic beverages were consumed and/or two or more occasions of illicit drug use, in the past 90 days, as assessed by the Assessment of Substance Use and Sexual Behavior questionnaire (CRF (F107));

• Has active cell phone service; is able to access his cell phone seven days a week between 6:00 PM and 6:00 AM the next morning; and is willing and able to use approximately 10 minutes of talk time and receive two text messages per day;

• Consistent internet access seven days a week between 6:00 PM and 6:00 AM the next morning;

• Ability to understand, read, and speak English;

• Ability to read at a fifth grade level, as assessed by the Rapid Estimate of Adolescent Literacy in Medicine (REALM)-TEEN; and

• Willingness to provide signed informed consent for study participation.

Exclusion Criteria

• HIV infected via modes other than sexual behavior (e.g., perinatally, via shared needles, or blood transfusion, etc.);
• Previously enrolled in Adolescent Trials Network (ATN) 112;
• Active psychiatric condition that in the opinion of the site Principal Investigator (PI) or designee would interfere with the ability to give true informed consent and to adhere to the study requirements;
• Visibly distraught and/or visibly emotionally unstable (e.g., exhibiting suicidal, homicidal, impulsive or violent behavior);
• Active drug or alcohol use or dependence that, in the opinion of the site personnel, would interfere with the ability to give true informed consent and to adhere to the study requirements;
• Acute illness that, in the opinion of the treating clinician, would interfere with the participant's ability to adhere to the protocol requirements and/or interfere with the protocol objectives.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: CROSSOVER

Arm && Interventions

Group	Intervention	Description
A: Begin with Interactive Voice Response (IVR) System	Structured daily diary	Group A participants are randomized the IVR system as Modality #1. After 33 days of diary completion using IVR, they switch to the interactive web response system (IWR)as Modality #2.
B: Begin with Interactive Web Response (IWR) System	Structured daily diary	Group B participants are randomized to the IWR system as Modality #1. After 33 days of diary completion using IWR, they switch to the interactive voice response (IVR)system as Modality #2.

Primary Outcome Measures

Name	Time	Method
Number of Participants who Complete the 66-Day Structured Daily Diary	66 days	The first primary objective of this study is to implement a 66-day structured daily diary with 90 HIV-positive YMSM to explore relationships among daily mood, stressful events, social support, substance use, sexual behavior, and adherence to ART among youth who are currently prescribed to take medication.
Rate of Completion of 66-Day Structured Daily Diary by Modality Type	66 days	The second primary objective is to explore the feasibility and acceptability of using two daily diary modalities (IVR and IWR) as (1) a novel method of data collection in research involving HIV-positive YMSM, and (2) a potential tool to provide personalized feedback and/or assist with self-monitoring among HIV-positive YMSM.
Reasons and Rate of for Non-completion of 66-Day Structured Daily Diary	66 days	The second primary objective is to explore the feasibility and acceptability of using two daily diary modalities (IVR and IWR) as (1) a novel method of data collection in research involving HIV-positive YMSM, and (2) a potential tool to provide personalized feedback and/or assist with self-monitoring among HIV-positive YMSM.

Secondary Outcome Measures

Name	Time	Method
Participant Responses to how Diary can Provide Personalized Feedback on Triggers to Risk Behaviors	66 days	The secondary objective of this study is to obtain feedback from HIV-positive YMSM on how the diary could be used to provide personalized feedback on triggers to risk behaviors, such as substance use, unprotected sexual behavior, and poor medication adherence. These data will be obtained through debriefing interviews.

Trial Locations

Locations (3)

Children's Hospital of Denver; 🇺🇸 Aurora, Colorado, United States

Wayne State University; 🇺🇸 Detroit, Michigan, United States

Childrens Hospital of Philadelphia; 🇺🇸 Philadelphia, Pennsylvania, United States